PREVISAN SA has a total of 12 patent applications. Its first patent ever was published in 1990. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and basic materials chemistry are BIOVASCULAR INC, HISTOCELL SL and STEM CELLS SPIN S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Hong Kong | 2 | |
#5 | United States | 2 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Object sterilising | |
#4 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Margery Helene | 12 |
#2 | Vandevelde Michel | 12 |
Publication | Filing date | Title |
---|---|---|
WO9810772A1 | Method for inhibiting desoxyribonucleotide triphosphate biosynthesis | |
US5585367A | Method of treating humans and animals infected with viruses of the retrovirus group | |
CA2080820A1 | Azo-derivatives, pharmaceutical preparations containing them, and their uses | |
WO9107876A1 | Active agent against retrovirus group viruses, compositions containing same and their use |